Drug Eluting Stents
Biosensors
Biosensors new generation of drug-eluting stents were created using the most advanced medical technology in its field. They offer patients many benefits by combining:
BA9™ with Biodegradable Polymer and Juno™ Stent Platform
- Proven safety of a DES with an abluminal coating that promotes an endothelial coverage similar to a bare metal stent (BMS), provides more targeted drug release and reduces the systemic exposure.
- A biodegradable polymer that is absorbed after 6 to 9 months.
- Proven efficacy of our drug, BA9™, that has 10 times more lipophilicity than sirolimus, resulting in a more targeted release to the vessel wall.
- Enhanced deliverability with advanced stent design.